FireStarter: DEA Registers 900+ Dispensaries, Massachusetts Votes Tomorrow, and MSO Earnings Begin

FireStarter The cannabis business news that matters, before your first meeting No. 1 · Mon, Nov 2

Good morning, and welcome to the first edition of FireStarter, IgniteIt’s daily rundown of the cannabis business news that matters before your first meeting. Every weekday morning we’ll pick the 10 stories operators, investors and brands should know, tell you what happened in a few lines, and flag what to watch next.

We’re launching in a big week. DEA has issued its first federal registrations, Massachusetts votes on repeal tomorrow, and MSO earnings start rolling in. Let’s get into it.

1DEA registers 900+ medical dispensaries in its first wave

Attorney General Todd Blanche announced Oct. 30 that DEA granted federal registration to more than 900 medical marijuana dispensaries in seven states: Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. DOJ called it the “first phase.” Manufacturers and distributors come next, and no companies were named.

What to watchWhich operators confirm they’re in, and how quickly registration shows up in 280E tax planning and banking conversations.

2A Nov. 29 supply-chain deadline for applicants

New DEA guidance lets medical businesses that filed and paid between April 28 and June 26 keep operating while their applications are pending. By Nov. 29, they must buy only from other applicants or registrants. Existing inventory can still be sold, and the guidance “does not carry the force of law.”

What to watchFour weeks is a short runway. Buyers, vendors and labs should be checking supplier registration status now.

3DEA rejects dual medical/adult-use licenses

In an order to a Minneapolis dispensary, DEA said Minnesota’s dual-purpose license does not count as a “state medical license.” It also objected to veterans qualifying by self-attestation. The business has 30 days to request a hearing or file a corrective plan.

What to watchOnly Minnesota is named, but the same logic could hit other states where one license covers both medical and adult-use sales. Expect operators to start asking about splitting licenses.

4Election Day is tomorrow

Massachusetts Question 8 would end adult-use sales on Jan. 1, 2028, while keeping medical sales and possession legal. A UMass Amherst/WCVB poll has it at 47% no and 31% yes, closer than earlier polls. Also on ballots: Idaho HJR 4, which would give only the Legislature the power to legalize, and Houston Prop A, which pairs lowest-priority possession enforcement with a no-knock warrant ban. In New Hampshire, Gov. Kelly Ayotte (R) repeated her veto threat, while challenger Cinde Warmington (D) backs legalization.

What to watchQ8 puts roughly $330 million a year in Massachusetts tax revenue at stake. A repeal win would be the first rollback of a mature adult-use market and a warning sign for every legal state.

5MSO earnings week kicks off

Curaleaf reports Q3 after the close Tuesday, Nov. 3, with a 5 p.m. ET call. Trulieve’s call is Thursday, Nov. 5 at 8:30 a.m. ET. Cresco reports before the open Friday, Nov. 6. For reference, Curaleaf posted $320.2 million in revenue in Q3 2025.

What to watchThese are the first calls since DEA registrations began. Listen for how many stores each company has registered, pending or in dual-license states.

6California: 95 businesses have split their licenses

California’s Department of Cannabis Control said 95 businesses have taken separate medical and adult-use licenses under emergency rules from June. It proposed permanent rules it estimates about 1,600 businesses could use. Comments are due Dec. 14, with a hearing Dec. 15. None of the 95 has DEA registration yet.

What to watchRead alongside item 3, this looks like a state-level workaround for DEA’s dual-license problem that other states may copy.

7New Jersey pushes its hemp drink cutoff to Dec. 11

The Assembly passed S4635 75-2, following a 37-0 Senate vote. The bill moves the cutoff for intoxicating hemp beverage sales from Nov. 13 to Dec. 11, or to the federal effective date if that’s later. It now goes to Gov. Mikie Sherrill.

What to watchA signature buys hemp beverage brands and retailers about a month more of New Jersey sales, which matters for holiday-quarter inventory.

8Rescheduling hearing: DEA wants the GAO report ignored

In an Oct. 29 brief, DEA asked Chief ALJ Derek Julius to give “no weight” to a GAO report that found DEA and FDA lack written scheduling procedures. Opponents, including SAM, three states and the Tennessee Bureau of Investigation, argued it should count heavily. Optional replies are due Thursday, Nov. 5.

What to watchThis is the last briefing step before the judge’s recommendation, and the main timing risk left for Schedule III.

9Tilray closes an Ontario grow site and raises guidance

Tilray said it will end operations at its Foss facility in Fenwick, Ontario, by Jan. 31, 2027. Cultivation moves to Masson, Quebec, and pre-rolls move to Cayuga. Tilray expects about US$10 million in annual savings and raised FY2027 adjusted EBITDA guidance to $70 million–$75 million.

What to watchCanadian producers keep consolidating capacity. Watch for more site closures as oversupply squeezes margins.

10Massachusetts Senate budget would shrink the CCC

Senate Ways and Means advanced SB 3290, a $2.61 billion supplemental budget. It includes about $6 million to carry out the 2026 marijuana modernization law, cuts the Cannabis Control Commission from five members to three (all named by the governor), and lets the CCC accept VA records for medical cards. The full Senate votes Nov. 5.

What to watchWhatever happens with Q8 tomorrow, this changes who regulates Massachusetts operators.
Also on our radar
  • A 50% tariff on Chinese hemp? Rep. Val Hoyle’s H.R. 10929 would add a 50% tariff on qualifying cannabinoid products from China and require testing of all cannabinoid imports. No cosponsors yet.
  • Ohio’s hemp ban and dispensary sales. A Marijuana Herald analysis found average weekly adult-use sales rose about 20%, from roughly $19.6 million to $23.6 million, after Ohio’s hemp restrictions took effect. Store count also grew, so the ban isn’t the only factor. For more on where Ohio goes from here, read our interview with Standard Wellness CEO Jared Maloof: “You Will See Prices Come Down, But It Will Take Time” →
The week ahead
Tue, Nov 3Election Day; Curaleaf Q3 after the close
Thu, Nov 5Rescheduling hearing replies due; Trulieve call; Massachusetts Senate budget vote
Fri, Nov 6Cresco Q3
Nov 12–13First federal hemp restrictions take effect
Nov 29DEA supply-chain deadline for applicants
That’s FireStarter. We’ll be back tomorrow with election results. See you then.

— Elliot
Quick poll
Would you like FireStarter in your inbox every morning?
Sources: Marijuana Moment (dual licenses; election; hearing); Greenfield Recorder (election); Yahoo Finance/Curaleaf and Trulieve IR (earnings); Marijuana Herald (California, New Jersey, Mass. budget, hemp tariff, Ohio); GlobeNewswire (Tilray).

Image
Guest Contributor
November 2, 2026
Share: